Drug Profile
Propofol phosphate
Alternative Names: Neuprox™; Propofol prodrugLatest Information Update: 06 Nov 2021
Price :
$50
*
At a glance
- Originator Vyrex Corporation
- Class General anaesthetics; Phenols; Small molecules
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Anaesthesia; Migraine; Neurological disorders; Parkinson's disease
Most Recent Events
- 31 Aug 2008 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 31 Aug 2008 Discontinued - Preclinical for Anaesthesia in USA (unspecified route)
- 31 Aug 2008 Discontinued - Preclinical for Migraine in USA (unspecified route)